Oxidative State in Cutaneous Melanoma Progression: A Question of Balance

Mascia Benedusi1, Heaji Lee2, Yunsook Lim2

  • 1Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.

PubMed

Insights

Reactive oxygen species (ROS) impact melanoma, with excessive production potentially driving tumor growth or apoptosis. This study explores ROS

Area of Science:

  • Oncology
  • Biochemistry
  • Dermatology

Background:

  • Reactive oxygen species (ROS) are key regulators of physiological processes and implicated in various diseases, including cancer.
  • Cutaneous melanoma, a highly aggressive skin cancer, is strongly linked to ultraviolet (UV) radiation exposure and excessive ROS production.
  • The precise role of ROS in melanoma metastasis remains incompletely understood, with evidence suggesting both pro-tumorigenic and cytotoxic effects.

Purpose of the Study:

  • To investigate the intricate relationship between cellular redox state and signaling pathways governing melanoma metastasis.
  • To review and discuss the potential of oxidative and antioxidant therapeutic strategies for managing metastatic melanoma.

Main Methods:

  • Literature review and analysis of existing research on ROS, melanoma progression, and therapeutic interventions.
  • Exploration of signaling pathways influenced by cellular redox balance in the context of melanoma metastasis.

Main Results:

  • Excessive ROS production in melanoma can paradoxically promote tumor cell proliferation and therapeutic resistance.
  • Conversely, elevated ROS levels can also induce apoptosis in melanoma cells, highlighting a dual role.
  • Specific signaling pathways linking redox state to metastatic processes were identified for further investigation.

Conclusions:

  • The dual role of ROS in melanoma progression necessitates a nuanced understanding for effective therapeutic targeting.
  • Targeting the cellular redox state presents a promising avenue for novel therapeutic strategies against metastatic melanoma.
  • Further research is crucial to elucidate the complex interplay between ROS and melanoma metastasis for clinical translation.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
1.8K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.1K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K